How much is CytoReason worth in 2026?

CytoReason has a current valuation of $159.8M based on their Later Stage VC round and secondary market data.

How much funding has CytoReason raised?

CytoReason has raised $123.0M in total funding across 0 funding rounds.

CytoReason

Website

CytoReason valuation and funding history | Last updated: July 15, 2024

Current Valuation

$159.8M

As of July 15, 2024

Total Funding Raised

$123.0M

Last Round

Later Stage VC

$80.0M

Last Funding

Jul 2024

Funding date

Capital Efficiency

1.30x

Valuation / Funding

Funding History & Valuation Timeline

Complete history of all funding rounds and valuation milestones

No funding history available

Funding data has not been imported for this company yet

Valuation Analysis

Current Valuation Metrics

CytoReason is currently valued at $159.8M as of July 15, 2024. The company has raised a total of $123.0M in funding.

Capital Efficiency

With a capital efficiency ratio of 1.30x, CytoReason has achieved a valuation that is 1.30 times the total capital raised.

Track CytoReason Valuation Updates

Get notified when CytoReason raises new funding or valuation changes

Explore More Data

Detailed analysis for CytoReason

Secondary Market Price

Real-time pricing data and trends

Valuation Tracker

Historical valuation changes

Funding History

Complete funding round timeline

Secondary Price History

Historical transaction data

All Investors

Complete list of all investors

View 5 companies free

Create a free account to unlock CytoReason's valuation history, funding rounds, and growth metrics.

No credit card required

What is CytoReason Worth in 2026?

CytoReason is a leading private company in the technology sector. Track CytoReason's valuation history, funding timeline, and implied market value from secondary transactions on Premier Alternatives.

How CytoReason Valuation is Determined

Private company valuations like CytoReason's are determined through primary funding rounds led by venture capital firms, private equity investors, and strategic partners. The valuation reflects factors including revenue growth, market opportunity, competitive positioning, and investor sentiment.